Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neurobiological Bases of Placebo Response in MDD
NCT01787240Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2012
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Nov 2012; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01787240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787240.